Cargando…
Alterations in Glycerolipid and Fatty Acid Metabolic Pathways in Alzheimer's Disease Identified by Urinary Metabolic Profiling: A Pilot Study
An easily accessible and non-invasive biomarker for the early detection of Alzheimer's disease (AD) is needed. Evidence suggests that metabolic dysfunction underlies the pathophysiology of AD. While urine is a non-invasively collectable biofluid and a good source for metabolomics analysis, it i...
Autores principales: | Watanabe, Yumi, Kasuga, Kensaku, Tokutake, Takayoshi, Kitamura, Kaori, Ikeuchi, Takeshi, Nakamura, Kazutoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578168/ https://www.ncbi.nlm.nih.gov/pubmed/34777195 http://dx.doi.org/10.3389/fneur.2021.719159 |
Ejemplares similares
-
Molecular Network Analysis of the Urinary Proteome of Alzheimer's Disease Patients
por: Watanabe, Yumi, et al.
Publicado: (2019) -
Urinary Apolipoprotein C3 Is a Potential Biomarker for Alzheimer's Disease
por: Watanabe, Yumi, et al.
Publicado: (2020) -
Urinary proteome profiles associated with cognitive decline in community elderly residents—A pilot study
por: Watanabe, Yumi, et al.
Publicado: (2023) -
A Patient with Fragile X-Associated Tremor/Ataxia Syndrome Presenting with Executive Cognitive Deficits and Cerebral White Matter Lesions
por: Kasuga, Kensaku, et al.
Publicado: (2011) -
Systematic review and meta-analysis of Japanese familial Alzheimer's disease and FTDP-17
por: Kasuga, Kensaku, et al.
Publicado: (2015)